Literature DB >> 11004341

Laparoscopic colorectal cancer surgery.

C A Maxwell-Armstrong1, M H Robinson, J H Scholefield.   

Abstract

BACKGROUND: A number of controversies exist in the laparoscopic treatment of colorectal cancer, and thus the technique has so far failed to gain widespread acceptance throughout the United Kingdom. This review aims to discuss these issues in the context of ongoing published trials, assessing both purported advantages and disadvantages.
METHODS: The United States National Library of Medicine Medline database, and the Bath Information Data Service (BIDS) were searched using keywords related to laparoscopic colorectal cancer surgery. Recent surgical journals were also reviewed for relevant publications. Attempts have been made to quote only the most recent work from institutions with multiple publications using the same group of patients, in order to present the most coherent picture. The data are presented as randomized controlled trials, nonrandomized controlled studies, and series comprising more than 10 patients.
CONCLUSIONS: This review confirms that laparoscopic colorectal cancer surgery is technically feasible. In addition patients lose less blood, have less immunosuppression, and have shorter postoperative ileus, in-patient stay, and require less analgesia. However, concerns still remain as to the development of port-site metastases, the longer operating times, and the overall cost of the equipment. In view of these concerns, the place of laparoscopically assisted colorectal cancer surgery is likely to remain controversial for some years yet. Randomized, controlled trials are as yet too few to provide definitive answers to all these issues.

Entities:  

Mesh:

Year:  2000        PMID: 11004341     DOI: 10.1016/s0002-9610(00)00390-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

Review 1.  Postoperative ileus: progress towards effective management.

Authors:  Kathrine Holte; Henrik Kehlet
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Restorative proctectomy with colon pouch-anal anastomosis by laparoscopic transanal pull-through: an available option for low rectal cancer?

Authors:  F Prete; F P Prete; R De Luca; P Nitti; D Sammarco; G Preziosa
Journal:  Surg Endosc       Date:  2006-10-23       Impact factor: 4.584

3.  Anti-inflammatory role of glycine in reducing rodent postoperative inflammatory ileus.

Authors:  B Stoffels; A Türler; J Schmidt; A Nazir; T Tsukamoto; B A Moore; C Schnurr; J C Kalff; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-10-01       Impact factor: 3.598

4.  Comparative evaluation of immune response after laparoscopical and open total mesorectal excisions with anal sphincter preservation in patients with rectal cancer.

Authors:  Jian-Kun Hu; Zong-Guang Zhou; Zhi-Xin Chen; Lan-Lan Wang; Yong-Yang Yu; Jin Liu; Bo Zhang; Li Li; Ye Shu; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

5.  Endogenous endotoxin participates in causing a panenteric inflammatory ileus after colonic surgery.

Authors:  Andreas Türler; Christoph Schnurr; Atsunori Nakao; Sandra Tögel; Beverley A Moore; Noriko Murase; Jörg C Kalff; Anthony J Bauer
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

6.  Long-term outcome and health-related quality of life after laparoscopic and open colectomy for benign disease.

Authors:  K Thaler; A Dinnewitzer; E Mascha; S Arrigain; E G Weiss; J J Nogueras; S D Wexner
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

7.  Port-site recurrence reproduced in the VX-2 rabbit carcinoma model: an in vivo model comparing laparoscopic port sites and open incisions.

Authors:  N W Wilkinson; A J Shapiro; S B Harvey; R S Stack; R L Cornum
Journal:  JSLS       Date:  2001 Jul-Sep       Impact factor: 2.172

8.  Laparoscopic right radical hemicolectomy.

Authors:  Sadhana V Deo; Shailesh P Puntambekar
Journal:  J Minim Access Surg       Date:  2012-01       Impact factor: 1.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.